Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation

Jonathan Douxfils

Santagata Davide: Thrombin Generation and Comparative Anticoagulant Pharmacodynamics
Aug 27, 2026, 14:40 | Science
Santagata Davide: Thrombin Generation and Comparative Anticoagulant Pharmacodynamics
Santagata Davide, Resident Doctor at University of Insubria, shared Joseph R. Shaw's post on LinkedIn,…
Joseph R. Shaw: Thrombin Generation and the Pharmacodynamics of Oral Anticoagulants
Aug 26, 2026, 14:23 | Science
Joseph R. Shaw: Thrombin Generation and the Pharmacodynamics of Oral Anticoagulants
Joseph R. Shaw, Director of Research Plus Program at Ottawa Department of Medicine, EHJ-CVP Associate…
Julie Vassart: Optimizing DOAC Detection in an Evolving Anticoagulant Landscape at ISTH 2026
Jul 13, 2026, 14:34 | Voices
Julie Vassart: Optimizing DOAC Detection in an Evolving Anticoagulant Landscape at ISTH 2026
Julie Vassart, Research Assistant at University of Namur, shared a post on LinkedIn: "I am…
Jonathan Douxfils: New Data on Hemostasis, VTE, and Breast Cancer to Rethink the Reference Standard
Jun 10, 2026, 15:23 | Voices
Jonathan Douxfils: New Data on Hemostasis, VTE, and Breast Cancer to Rethink the Reference Standard
Jonathan Douxfils, Director of the Clinical Pharmacology and Toxicology Research Unit at University of Namur,…
Jonathan Douxfils: Why Measuring NETosis Remains a Major Challenge in Translational Research
May 19, 2026, 10:45 | Science
Jonathan Douxfils: Why Measuring NETosis Remains a Major Challenge in Translational Research
Jonathan Douxfils, Director of the Clinical Pharmacology and Toxicology Research Unit at University of Namur,…
Joseph R. Shaw: Thrombin Generation as a Pharmacodynamic Framework for Anticoagulant Therapy
May 15, 2026, 16:43 | Science
Joseph R. Shaw: Thrombin Generation as a Pharmacodynamic Framework for Anticoagulant Therapy
Joseph R. Shaw, Director of Research+ Program at Ottawa Department of Medicine, EHJ-CVP Associate Editor…
Jonathan Douxfils: A Critical Review of NETosis Measurement Methods and the Need for Standardization
May 14, 2026, 14:31 | Science
Jonathan Douxfils: A Critical Review of NETosis Measurement Methods and the Need for Standardization
Jonathan Douxfils, Director of the Clinical Pharmacology and Toxicology Research Unit at University of Namur,…
Jonathan Douxfils: In Contraception for Healthy Women, Safety Must Remain the Leading Criterion
Mar 8, 2026, 10:47 | Voices
Jonathan Douxfils: In Contraception for Healthy Women, Safety Must Remain the Leading Criterion
Jonathan Douxfils, Director of the Clinical Pharmacology and Toxicology Research Unit at University of Namur,…
Lucie Raskin: New FAERS Evidence Suggests Lower VTE Risk With Natural Estrogen COCs
Mar 5, 2026, 15:17 | Science
Lucie Raskin: New FAERS Evidence Suggests Lower VTE Risk With Natural Estrogen COCs
Lucie Raskin, PhD student at University of Namur, shared on LinkedIn about a recent article she…
Jonathan Douxfils: Are All Progestin-Only Contraceptives Truly 'Neutral' for VTE Risk?
Feb 28, 2026, 14:52 | Voices
Jonathan Douxfils: Are All Progestin-Only Contraceptives Truly 'Neutral' for VTE Risk?
Jonathan Douxfils, Director of the Clinical Pharmacology and Toxicology Research Unit at University of Namur,…
Sara Ng: Predicting Contraceptive VTE Risk Years Before Market
Dec 21, 2025, 07:00 | Science
Sara Ng: Predicting Contraceptive VTE Risk Years Before Market
Sara Ng, Staff Specialist Haematologist at South Western Sydney Local Health District, shared a post…
Jonathan Douxfils: Can We Estimate the VTE Risk of a Pill Before a Million Women Use It?
Dec 7, 2025, 16:21 | Science
Jonathan Douxfils: Can We Estimate the VTE Risk of a Pill Before a Million Women Use It?
Jonathan Douxfils, Board Member of Belgian Society on Thrombosis and Haemostasis, shared on LinkedIn: ''Can…
Jonathan Douxfils on VTE Risk Associated With Relugolix–Estradiol–Norethisterone Acetate Combination
Nov 28, 2025, 04:25 | Science
Jonathan Douxfils on VTE Risk Associated With Relugolix–Estradiol–Norethisterone Acetate Combination
Jonathan Douxfils, Board Member of Belgian Society on Thrombosis and Haemostasis, shared on LinkedIn: ''New…
Heparins Outperform DOACs and FXII/FXI Inhibitors in Preventing Thrombin Generation: JTH Study
Sep 2, 2025, 13:39 | Insight
Heparins Outperform DOACs and FXII/FXI Inhibitors in Preventing Thrombin Generation: JTH Study
Journal of Thrombosis and Haemostasis (JTH) shared an insightful post on LinkedIn: “Effect of heparins,…
All: 14 Posts: 1 - 100
NewsFeed